Equity Details
Price & Market Data
Price: $1.02
Daily Change: -$0.04 / 3.92%
Daily Range: $1.01 - $1.06
Market Cap: $111,406,536
Daily Volume: 809,075
Performance Metrics
1 Week: -5.96%
1 Month: 17.79%
3 Months: 38.35%
6 Months: -37.12%
1 Year: -52.76%
YTD: -34.29%
About MaxCyte, Inc. (MXCT)
An in-depth look at MaxCyte, Inc. (MXCT). Current price: 1.02, daily change: -$0.04 / 3.92%. Market cap: 111,406,536. All key performance indicators for a thorough understanding.
Company Details
Employees: 91
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
